CenterStar Asset Management’s AstraZeneca AZN Stock Holding History

CenterStar Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.46M	Buy	7,400 +3,150	+74%	+$607K	0.18%	116
2025 Q4	$781K	Sell	4,250 -1,650	-28%	-$289K	0.22%	110
2025 Q3	$905K	Buy	+5,900	New	+$893K	0.19%	123
2025 Q2	–	Sell	-2,550	Closed	-$375K	–	230
2025 Q1	$375K	Buy	+2,550	New	+$369K	0.09%	237
2024 Q3	–	Sell	-4,300	Closed	-$671K	–	291
2024 Q2	$671K	Buy	+4,300	New	+$647K	0.19%	129
2024 Q1	–	Sell	-2,400	Closed	-$323K	–	253
2023 Q4	$323K	Buy	+2,400	New	+$312K	0.05%	240
2023 Q1	–	Hold	0	–	-$2.36K	–	196
2022 Q4	–	Hold	0	–	–	–	25
2022 Q3	–	Hold	0	–	–	–	186
2022 Q2	–	Hold	0	–	–	–	26
2022 Q1	–	Hold	0	–	–	–	26
2021 Q3	–	Hold	0	–	-$4.82M	–	677
2021 Q2	–	Hold	0	–	–	–	33
2021 Q1	–	Hold	0	–	–	–	198
2020 Q2	–	Hold	0	–	-$20K	–	720
2020 Q1	–	Hold	0	–	–	–	516
2019 Q4	–	Hold	0	–	-$2K	–	486
2019 Q3	–	Hold	0	–	–	–	409

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

CenterStar Asset Management's AZN Position: Q4 2025 in Review

CenterStar Asset Management sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 3,340 shares — an estimated $586K sold.

CenterStar Asset Management first reported a position in AZN in Q1 2025 and held it in 2 quarters. The position peaked at $512K in Q3 2025. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

CenterStar Asset Management reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
CenterStar Asset Management sold 3,340 AstraZeneca shares in Q4 2025, an estimated $586K.
CenterStar Asset Management first reported a position in AstraZeneca in Q1 2025 and held it in 2 quarters.
CenterStar Asset Management's AstraZeneca position peaked at $512K in Q3 2025.
1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on CenterStar Asset Management's 13F filing for Q4 2025, filed 27 Jan 2026.